Garnish, Sarah E.
Meng, Yanxiang http://orcid.org/0000-0001-7447-9788
Koide, Akiko
Sandow, Jarrod J. http://orcid.org/0000-0001-5684-8236
Denbaum, Eric
Jacobsen, Annette V. http://orcid.org/0000-0003-0252-7685
Yeung, Wayland
Samson, Andre L. http://orcid.org/0000-0002-0637-2716
Horne, Christopher R. http://orcid.org/0000-0003-1318-514X
Fitzgibbon, Cheree
Young, Samuel N.
Smith, Phoebe P. C. http://orcid.org/0000-0001-7062-9312
Webb, Andrew I. http://orcid.org/0000-0001-5061-6995
Petrie, Emma J.
Hildebrand, Joanne M. http://orcid.org/0000-0002-1456-2042
Kannan, Natarajan
Czabotar, Peter E. http://orcid.org/0000-0002-2594-496X
Koide, Shohei http://orcid.org/0000-0001-5473-4358
Murphy, James M. http://orcid.org/0000-0003-0195-3949
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (2002965, 1079700, 1172929, 9000653)
U.S. Department of Health & Human Services | National Institutes of Health (5R01GM114409, 1R35GM139656)
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 8 September 2020
Accepted: 15 March 2021
First Online: 13 April 2021
Competing interests
: S.E.G., A.L.S., C.F., S.N.Y., E.J.P., J.M.H., P.E.C., and J.M.M. contribute, or have contributed, to a project developing necroptosis inhibitors in collaboration with Anaxis Pharma Pty Ltd. A.K. and S.K. are listed as inventors on issued and pending patents on the Monobody technology filed by The University of Chicago (US Patent 9512199 B2 and related pending applications). The other authors declare no competing interests.